Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
SGLT1/SGLT2 inhibition
.
Show all posts
Showing posts with label
SGLT1/SGLT2 inhibition
.
Show all posts
Sunday, September 9, 2012
Lexicon announces results from two initial trials of LX4211 for type 2 diabetes
›
T hirty-six patients with type 2 diabetes mellitus (T2DM) were randomized 1:1:1 to receive a once-daily oral dose of placebo or 150 or 300...
›
Home
View web version
